Skip to content

The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras

The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01080287
Enrollment
60
Registered
2010-03-04
Start date
2009-09-30
Completion date
2011-09-30
Last updated
2012-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

autonomic, orthostatic, syncope, biopsy, prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance, characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis

Brief summary

This is a study to compare subject response and symptoms resulting from administration of three clinical assessments. \* The 3 assessments are 1. passive upright tilt table testing, 2. quantitative sudomotor axon reflex testing (QSART)and 3. punch biopsy. The comparison of results will be from two subject groups: * Group A, the migraine suffering patient with or without aura * Group B, the migraine suffering patient with or without aura who has diagnosed orthostatic intolerance (i.e.,feeling dizzy or faint when making a body position change).

Interventions

None listed

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 18 to 65 * male or female * migraine diagnosis * may or may not have orthostatic intolerance * able to demonstrate study understanding and complete informed consent process

Exclusion criteria

* subjects who do not meet inclusion criteria * subjects unable to complete informed consent process

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026